WFG Advisors’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$152K Hold
1,500
0.03% 427
2017
Q1
$173K Buy
1,500
+900
+150% +$105K 0.05% 362
2016
Q4
$72K Sell
600
-100
-14% -$11.1K 0.02% 622
2016
Q3
$79K Buy
+700
New +$80.6K 0.02% 584
2016
Q2
Sell
-400
Closed -$45K 1580
2016
Q1
$45K Sell
400
-600
-60% -$62.3K 0.01% 688
2015
Q4
$109K Hold
1,000
0.03% 445
2015
Q3
$100K Buy
1,000
+200
+25% +$21.8K 0.03% 472
2015
Q2
$91K Hold
800
0.03% 560
2015
Q1
$84K Buy
+800
New +$85.2K 0.02% 583
2014
Q4
Sell
-95
Closed -$14K 2092
2014
Q3
$14K Hold
95
﹤0.01% 1383
2014
Q2
$16K Buy
95
+45
+90% +$8.01K ﹤0.01% 1342
2014
Q1
$10K Buy
50
+33
+194% +$6.23K ﹤0.01% 1457
2013
Q4
$3K Hold
17
﹤0.01% 1863
2013
Q3
$3K Buy
+17
New +$2.64K ﹤0.01% 1830

Other funds holding CLB

WFG Advisors's CLB Position: Q2 2017 in Review

WFG Advisors held its Core Laboratories (CLB) position steady in Q2 2017 at 1,500 shares worth $152K. The position accounts for 0.03% of the portfolio, ranked #427.

WFG Advisors first reported a position in CLB in Q3 2013 and has held it in 14 quarters since. The position peaked at $173K in Q1 2017. 360 funds tracked by Wall St. Rank hold CLB as of Q2 2017.

  • WFG Advisors held 1,500 shares of Core Laboratories worth $152K as of Q2 2017.
  • WFG Advisors left its Core Laboratories share count unchanged in Q2 2017.
  • Core Laboratories made up 0.03% of WFG Advisors's portfolio in Q2 2017, its #427 holding.
  • WFG Advisors first reported a position in Core Laboratories in Q3 2013 and has held it in 14 quarters since.
  • WFG Advisors's Core Laboratories position peaked at $173K in Q1 2017.
  • 360 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2017.

Based on WFG Advisors's 13F filing for Q2 2017, filed 18 Aug 2017.